You are here: Industry Insights > ANI

News List

ANI Pharma enhances generics and CDMO business through Novitium acquisition CPhIonline
November 29, 2021
The transaction expands ANI’s R&D pipeline and adds nine new customers to its growing CDMO business.
ANI Acquires Branded Products Portfolio from Sandoz contractpharma
April 08, 2021
ANI Pharmaceuticals Inc. has acquired the new drug applications (NDAs) for Oxistat Lotion, Veregen Ointment, and Pandel Cream and the abbreviated new drug application (ANDA) for ApexiCon E Cream from Sandoz Inc. Pandel Cream will be transitioned ...
ANI Pharmaceuticals Strengthens CDMO Biz contractpharma
March 12, 2021
ANI Pharmaceuticals has struck a $163.5 million deal to acquire Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities.
ANI Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules americanpharmaceuticalreview
March 04, 2020
ANI Pharmaceuticals has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for Memantine Hydrochloride Extended-Release Capsules 7 mg, 14 mg, 21 mg and 28 mg.
ANI Announces FDA Approval of Potassium Citrate Extended-Release Tablets americanpharmaceuticalreview
January 19, 2020
ANI Pharmaceuticals has received approval of the Company's abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for Potassium Citrate Extended-Release Tablets USP, 10 mEq and 15 mEq.
ANI Pharmaceuticals Expands Generic Pipeline contractpharma
June 19, 2019
Acquires seven development stage drug products from Coeptis.